# Loop Industries, Inc.: financial statements, quarterly

LOOP · Nasdaq · CIK 1504678 · [Materials](/sectors/materials.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/loop.md) · [Financials](/companies/loop/financials.md) · [Filings](/companies/loop/filings.md) · [Insiders](/companies/loop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/loop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001654954-25-000379.md) | [0.0 d](/filings/0001654954-25-006337.md) | [0.0](/filings/0001654954-25-008086.md) | [0.0](/filings/0001437749-25-031037.md) | [0.1](/filings/0001654954-25-000379.md) | [10.8 d](/filings/0001437749-26-018576.md) | [0.3](/filings/0001654954-25-008086.md) | [0.0](/filings/0001437749-25-031037.md) | [0.1](/filings/0001437749-26-001273.md) | [0.2 d](/filings/0001437749-26-018576.md) | [0.2](/filings/0001437749-26-023542.md) | [0.1](/filings/0001437749-26-032746.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001437749-26-023542.md) | [0.0](/filings/0001437749-26-032746.md) | not reported | not reported | [0.2](/filings/0001437749-26-023542.md) | [0.1](/filings/0001437749-26-032746.md) |
| Research and development | $m | [1.8](/filings/0001654954-25-000379.md) | [3.0 d](/filings/0001654954-25-006337.md) | [2.2](/filings/0001654954-25-008086.md) | [1.9](/filings/0001437749-25-031037.md) | [1.4](/filings/0001437749-26-001273.md) | [1.1 d](/filings/0001437749-26-018576.md) | [1.3](/filings/0001437749-26-023542.md) | [0.8](/filings/0001437749-26-032746.md) | [1.0](/filings/0001437749-26-001273.md) | [0.3 d](/filings/0001437749-26-018576.md) | [1.0](/filings/0001437749-26-023542.md) | [0.5](/filings/0001437749-26-032746.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(4.2)](/filings/0001654954-25-000379.md) | [(5.1) d](/filings/0001654954-25-006337.md) | [(5.2)](/filings/0001654954-25-008086.md) | [(4.8)](/filings/0001437749-25-031037.md) | [(11.9)](/filings/0001437749-26-001273.md) | [6.9 d](/filings/0001437749-26-018576.md) | [(3.4)](/filings/0001437749-26-023542.md) | [(3.2)](/filings/0001437749-26-032746.md) | [(2.9)](/filings/0001437749-26-001273.md) | [(2.7) d](/filings/0001437749-26-018576.md) | [(3.4)](/filings/0001437749-26-023542.md) | [(3.0)](/filings/0001437749-26-032746.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001654954-25-000379.md) | not reported | [(0.11)](/filings/0001654954-25-008086.md) | not reported | [(0.25)](/filings/0001654954-25-000379.md) | not reported | [(0.07)](/filings/0001654954-25-008086.md) | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | [(0.10)](/filings/0001437749-25-031037.md) | [(0.25)](/filings/0001437749-26-001273.md) | not reported | [(0.07)](/filings/0001437749-26-023542.md) | [(0.07)](/filings/0001437749-26-032746.md) | [(0.06)](/filings/0001437749-26-001273.md) | not reported | [(0.07)](/filings/0001437749-26-023542.md) | [(0.06)](/filings/0001437749-26-032746.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: not reported
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | period not labelled (2024-09-29) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.0](/filings/0001654954-25-000379.md) | [5.3](/filings/0001654954-24-008942.md) | [1.4](/filings/0001654954-24-012999.md) | [7.0](/filings/0001654954-24-007029.md) | [0.3](/filings/0001654954-25-000379.md) | [13.0](/filings/0001437749-26-018576.md) | [9.7](/filings/0001654954-25-008086.md) | [7.3](/filings/0001437749-25-031037.md) | [5.2](/filings/0001437749-26-001273.md) | [2.4](/filings/0001437749-26-032746.md) | [1.1](/filings/0001437749-26-023542.md) | [0.8](/filings/0001437749-26-032746.md) |
| Current assets | $m | [8.0](/filings/0001654954-25-006337.md) | [6.2](/filings/0001654954-24-008942.md) | [2.4](/filings/0001654954-24-012999.md) | not reported | [1.0](/filings/0001654954-25-000379.md) | [13.9](/filings/0001437749-26-018576.md) | [11.3](/filings/0001654954-25-008086.md) | [8.8](/filings/0001437749-25-031037.md) | [6.0](/filings/0001437749-26-001273.md) | [3.6](/filings/0001437749-26-032746.md) | [2.2](/filings/0001437749-26-023542.md) | [1.6](/filings/0001437749-26-032746.md) |
| Total assets | $m | [20.6](/filings/0001654954-25-006337.md) | [18.7](/filings/0001654954-24-008942.md) | [15.0](/filings/0001654954-24-012999.md) | not reported | [4.7](/filings/0001654954-25-000379.md) | [18.6](/filings/0001437749-26-018576.md) | [15.9](/filings/0001654954-25-008086.md) | [13.3](/filings/0001437749-25-031037.md) | [11.3](/filings/0001437749-26-001273.md) | [8.6](/filings/0001437749-26-032746.md) | [6.7](/filings/0001437749-26-023542.md) | [6.4](/filings/0001437749-26-032746.md) |
| Current liabilities | $m | [2.4](/filings/0001654954-25-006337.md) | [3.1](/filings/0001654954-24-008942.md) | [4.9](/filings/0001654954-24-012999.md) | not reported | [8.1](/filings/0001654954-25-000379.md) | [4.0](/filings/0001437749-26-018576.md) | [4.0](/filings/0001654954-25-008086.md) | [3.9](/filings/0001437749-25-031037.md) | [3.5](/filings/0001437749-26-001273.md) | [2.8](/filings/0001437749-26-032746.md) | [3.2](/filings/0001437749-26-023542.md) | [4.8](/filings/0001437749-26-032746.md) |
| Total liabilities | $m | [6.4](/filings/0001654954-25-006337.md) | [9.5](/filings/0001654954-24-008942.md) | [10.2](/filings/0001654954-24-012999.md) | not reported | [11.6](/filings/0001654954-25-000379.md) | [18.2](/filings/0001437749-26-018576.md) | [18.6](/filings/0001654954-25-008086.md) | [18.8](/filings/0001437749-25-031037.md) | [18.6](/filings/0001437749-26-001273.md) | [18.1](/filings/0001437749-26-032746.md) | [18.7](/filings/0001437749-26-023542.md) | [20.5](/filings/0001437749-26-032746.md) |
| Long-term debt | $m | [3.2](/filings/0001654954-25-006337.md) | [5.6](/filings/0001654954-24-008942.md) | [4.5](/filings/0001654954-24-012999.md) | not reported | [2.7](/filings/0001654954-25-000379.md) | [2.8](/filings/0001437749-26-018576.md) | [2.8](/filings/0001654954-25-008086.md) | [2.7](/filings/0001437749-25-031037.md) | [2.5](/filings/0001437749-26-001273.md) | [2.4](/filings/0001437749-26-032746.md) | [2.2](/filings/0001437749-26-023542.md) | [2.0](/filings/0001437749-26-032746.md) |
| Current portion of debt | $m | [0.1](/filings/0001654954-25-006337.md) | [0.2](/filings/0001654954-24-008942.md) | [0.4](/filings/0001654954-24-012999.md) | not reported | [0.5](/filings/0001654954-25-000379.md) | [0.3](/filings/0001437749-26-018576.md) | [0.4](/filings/0001654954-25-008086.md) | [0.5](/filings/0001437749-25-031037.md) | [0.5](/filings/0001437749-26-001273.md) | [0.6](/filings/0001437749-26-032746.md) | [0.8](/filings/0001437749-26-023542.md) | [0.9](/filings/0001437749-26-032746.md) |
| Shareholders' equity | $m | [14.1](/filings/0001654954-24-012999.md) | [9.3](/filings/0001437749-25-031037.md) | [4.8](/filings/0001437749-26-001273.md) | not reported | [(6.9)](/filings/0001437749-26-001273.md) | [0.4](/filings/0001437749-26-032746.md) | [(2.7)](/filings/0001437749-26-032746.md) | [(5.5)](/filings/0001437749-26-032746.md) | [(7.3)](/filings/0001437749-26-001273.md) | [(9.6)](/filings/0001437749-26-032746.md) | [(12.0)](/filings/0001437749-26-032746.md) | [(14.1)](/filings/0001437749-26-032746.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,745) d](/filings/0001654954-25-000379.md) | [(3,284) d](/filings/0001654954-25-006337.md) | [(3,915)](/filings/0001654954-25-008086.md) | [(2,860) d](/filings/0001437749-25-031037.md) | [(1,860) d](/filings/0001437749-26-001273.md) | [6,514 d](/filings/0001437749-26-018576.md) | [(3,082)](/filings/0001437749-26-023542.md) | [(2,522) d](/filings/0001437749-26-032746.md) | [(1,768) d](/filings/0001437749-26-001273.md) | [(2,738) d](/filings/0001437749-26-018576.md) | [(1,229)](/filings/0001437749-26-023542.md) | [(1,165) d](/filings/0001437749-26-032746.md) |
| Capital expenditure | $k | [10.0 d](/filings/0001654954-25-000379.md) | [5,152 d](/filings/0001654954-25-006337.md) | not reported | not reported | not reported | [0.0 d](/filings/0001654954-25-006337.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [47.5](/filings/0001654954-25-000379.md) | [0.0](/filings/0001654954-25-008086.md) | [47.6](/filings/0001654954-25-000379.md) | [0.0](/filings/0001654954-25-008086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,812,574 at 2026-10-15, from the cover of the [10-Q filed 2026-10-16](/filings/0001437749-26-032746.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.